Cannatrek, a leading Australian medicinal cannabis company, has announced today that its hero product, Cannatrek T25® Topaz Flower, is on the cusp of reaching its 500,000th unit sold in Australia. Since its launch, T25® Topaz has become a trusted prescription product by GPs for their patients.
This milestone is a testament to the continuous quality and reliability of T25® Topaz.
To date, the T25® Topaz flower holds the distinction of being the number #1 most prescribed and consistent medical cannabis product in Australia.
In addition, with the continuous supply of T25® Topaz flower, Cannatrek is pleased to have the ongoing support with its industry partners and remains committed to providing a dependable and uninterrupted supply of this product to those who require it.
